Dr. David Soler received his Ph.D. in Molecular Biology at Kent State University and an M.S. in Immunology at the University of Barcelona. He obtained an undergraduate double major in Biochemistry and Biology at the University of Navarra. He completed his postdoctoral degree in the Department of Dermatology at Case Western Reserve University. He currently has 18 first-author papers. His current interests include developing blood-based liquid-biopsy tests to identify Glioblastoma multiforme (GBM) recurrence. He is also focused on finding innovative and practical ways to combat GBM using CAR-T cells. He is very open to collaborations and finding innovative ways to tackle human disease and basic biology problems such as mass-producing membrane proteins for structural studies or rescuing plasma membrane expression for problem proteins.